Clinical Trials Browser

Phase 2 × Hepatoblastoma × Irinotecan × Clear all

NCT00287976 2013-09-17

Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms, Hepatoblastoma